Correspondence 0001493152-23-026046 from Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)

Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Date: July 31, 2023 · CIK: 0000793171 · Accession: 0001493152-23-026046

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-267366

Date

July 17, 2023

Author

/s/

Form

CORRESP

Company

Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)

Letter

Cherry Creek Drive South, Suite 720

Denver, Colorado 80209

July 31, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Attn: Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn

Re: Vitro Biopharma, Inc.

Registration Statement on Form S-1

Filed on July 17, 2023

File No. 333-267366

Ladies and Gentleman:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned registrant hereby respectfully requests that the effective date of the Registration Statement on Form S-1 referred to above (the “Registration Statement”) be accelerated so that the same will become effective at 5:00 p.m. Eastern Time on August 2, 2023, or as soon thereafter as practicable. In making this acceleration request, the undersigned registrant acknowledges that it is aware of its obligations under the Act.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Polsinelli PC, by calling Scott Berdan at (303) 583-8235.

Thank you for your assistance with this matter.

Sincerely,
VITRO BIOPHARMA, INC.

Show Raw Text

CORRESP
1
filename1.htm

3200
Cherry Creek Drive South, Suite 720

Denver,
Colorado 80209

July
31, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

Attn:
Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn

  Re:
  Vitro Biopharma,
  Inc.

Registration
Statement on Form S-1

Filed
on July 17, 2023

File
No. 333-267366

Ladies
and Gentleman:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned registrant hereby respectfully
requests that the effective date of the Registration Statement on Form S-1 referred to above (the “Registration Statement”)
be accelerated so that the same will become effective at 5:00 p.m. Eastern Time on August 2, 2023, or as soon thereafter as practicable.
In making this acceleration request, the undersigned registrant acknowledges that it is aware of its obligations under the Act.

Once
the Registration Statement has been declared effective, please orally confirm that event with our counsel, Polsinelli PC, by calling
Scott Berdan at (303) 583-8235.

Thank
you for your assistance with this matter.

    Sincerely,

    VITRO BIOPHARMA, INC.

    /s/
    Nathan Haas

    Name:
    Nathan Haas

    Title:
    Chief Financial Officer

    cc:
    Scott
    Berdan, Esq., Polsinelli PC

    Tyler
    Weigel, Esq., Polsinelli PC

    Shashi
    Khiani, Esq., Polsinelli PC

SecProbe.io